What Forma Therapeutics Holdings, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Shegog Todd | SVP, Chief Financial Officer | Oct 14 | Tender Offer · U | −56,143 | — | — | 0 |
| Ra Capital MANAGEMENT, L.p. | Director | Oct 14 | Tender Offer · U | −1,511,425 | — | — | 0 |
| Ra Capital MANAGEMENT, L.p. | Director | Oct 14 | Tender Offer · U | −7,500,226 | — | — | 0 |
| Ra Capital MANAGEMENT, L.p. | Director | Oct 14 | Tender Offer · U | −7,250 | — | — | 0 |
| Lee Frank D. | President and CEO | Oct 14 | Tender Offer · U | −201,436 | — | — | 0 |
| Potts Jeannette | See Remarks | Oct 14 | Tender Offer · U | −43,958 | — | — | 0 |
| Potts Jeannette | See Remarks | Oct 14 | Tender Offer · U | −3,400 | — | — | 0 |
| Frederick Wayne A.i. | Director | Oct 14 | Tender Offer · U | −7,250 | — | — | 0 |
| Bishop John E | SVP, Chief Technology Officer | Oct 14 | Tender Offer · U | −47,950 | — | — | 0 |
| Wiggans Thomas G | Director | Oct 14 | Tender Offer · U | −7,250 | — | — | 0 |
| Wirth Peter | Director | Oct 14 | Tender Offer · U | −7,250 | — | — | 0 |
| Wirth Peter | Director | Oct 14 | Tender Offer · U | −127,665 | — | — | 0 |
| Clackson Timothy P | Director | Oct 14 | Tender Offer · U | −7,250 | — | — | 0 |
| Clackson Timothy P | Director | Oct 14 | Tender Offer · U | −23,590 | — | — | 0 |
| Molina Arturo Md | Director | Oct 14 | Tender Offer · U | −10,000 | — | — | 0 |
| Melian Agustin | EVP, Research & Development | Oct 14 | Tender Offer · U | −79,000 | — | — | 0 |
| Fanucci Marsha | Director | Oct 14 | Tender Offer · U | −7,250 | — | — | 0 |
| Fanucci Marsha | Director | Oct 14 | Tender Offer · U | −52,532 | — | — | 0 |
| Lesser Brian Andrew | SVP, Commercial Officer | Oct 14 | Tender Offer · U | −42,593 | — | — | 0 |
| Lesser Brian Andrew | SVP, Commercial Officer | Oct 14 | Tender Offer · U | −10,000 | — | — | 0 |
Loading...
